ストックスクリーナーアプリを入手
9.22
2.79%
0.25
アフターアワーズ：
9.22
前日終値:
$8.97
開ける：
$8.97
24時間の取引高:
578.76K
Relative Volume:
0.91
時価総額：
$326.51M
収益：
$127.70M
当期純損益:
$-108.14M
株価収益率:
-11.24
EPS:
-0.82
ネットキャッシュフロー:
$-117.52M
1週間 パフォーマンス:
+7.46%
1か月 パフォーマンス:
-7.98%
6か月 パフォーマンス:
-20.93%
1年 パフォーマンス:
-10.83%
1日の値動き範囲:
$8.70
$9.265
1週間の範囲:
$8.41
$9.265
52週間の値動き範囲:
$8.41
$18.75
Iteos Therapeutics Inc Stock (ITOS) Company Profile
Iteos Therapeutics Inc Stock (ITOS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-05-05 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-08 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-18 | 開始されました | JP Morgan | Overweight |
| 2020-08-18 | 開始されました | Piper Sandler | Overweight |
| 2020-08-18 | 開始されました | SVB Leerink | Outperform |
| 2020-08-18 | 開始されました | Wedbush | Outperform |
すべてを表示
Iteos Therapeutics Inc (ITOS) 最新ニュース
Iteos Therapeutics stock hits 52-week low at $8.49 By Investing.com - Investing.com South Africa
Iteos Therapeutics stock hits 52-week low at $8.49 - Investing.com
iTeos Therapeutics präsentiert auf dem Immunonkologie-Kongress der ESMO präklinische und translationale Daten sowie Daten aus der klinischen Phase-II-Studie A2A-005 zu Inupadenant bei NSCLC in der Zweitlinie - GlobeNewswire Inc.
iTeos Therapeutics to Highlight Inupadenant Preclinical, - GlobeNewswire
iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress - StockTitan
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Purchased by nVerses Capital LLC - Defense World
Iteos Therapeutics stock hits 52-week low at $8.73 - Investing.com India
Iteos Therapeutics stock hits 52-week low at $8.73 By Investing.com - Investing.com Canada
Exchange Traded Concepts LLC Sells 6,414 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
iTeos Looking At A Strong Finish To 2024 After Going From Fifth To First In TIGIT - Citeline
(ITOS) Proactive Strategies - Stock Traders Daily
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Position Decreased by AQR Capital Management LLC - MarketBeat
BOXER CAPITAL, LLC Expands Stake in ITeos Therapeutics Inc - GuruFocus.com
ITeos Therapeutics Inc (ITOS) shows promising results - US Post News
Stock Performance Spotlight: ITeos Therapeutics Inc (ITOS) Ends the Day at 9.73, Down by -2.21 - The Dwinnex
ITOS Stock on the Rise: A Promising Investment - The InvestChronicle
Millennium Management LLC Decreases Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Millennium Management LLC Lowers Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Short Interest Update - Defense World
Squarepoint Ops LLC Sells 38,801 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
When (ITOS) Moves Investors should Listen - Stock Traders Daily
Did ITeos Therapeutics Inc (ITOS) perform well in the last session? - US Post News
Ratio Revelations: ITeos Therapeutics Inc (ITOS)’s Financial Metrics in the Spotlight - The Dwinnex
TIGITs Trend Upward After iTeos/GSK Present Positive Data at ESMO - BioSpace
Dimensional Fund Advisors LP Raises Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
ITeos TherapeuticsAssessing Breakthrough Therapies To Treat Cancer - RTTNews
A new trading data show ITeos Therapeutics Inc (ITOS) is showing positive returns. - SETE News
American Century Companies Inc. Has $687,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
A closer look at ITeos Therapeutics Inc (ITOS)’s stock price trends - US Post News
Financial Metrics Exploration: Understanding ITeos Therapeutics Inc (ITOS) Through Ratios - The Dwinnex
How the (ITOS) price action is used to our Advantage - Stock Traders Daily
TANG CAPITAL MANAGEMENT LLC Acquires New Stake in ITeos Therapeu - GuruFocus.com
156,894 Shares in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Bought by Clearline Capital LP - Defense World
Clearline Capital LP Invests $2.33 Million in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
There is no way ITeos Therapeutics Inc (ITOS) can keep these numbers up - SETE News
ESMO recap: Keeping TIGIT alive, Rybrevant & immunotherapy anniversary — a BioCentury podcast - BioCentury
ITeos Therapeutics Inc (ITOS) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Renaissance Technologies LLC Sells 157,700 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Rhumbline Advisers - Defense World
Renaissance Technologies LLC Has $8.30 Million Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
Analytical Lens: Exploring ITeos Therapeutics Inc (ITOS)’s Financial Story Through Ratios - The Dwinnex
The week in pharma: action, reaction and insight – week to September 2024 | Pharmaceutical | The Pharmaletter - The Pharma Letter
(ITOS) Investment Report - Stock Traders Daily
Sept. 13-20 Undercovered Stock Picks: Aura Biosciences, APA Corporation, iTeos, CuriosityStream + - Seeking Alpha
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Holdings Lifted by Victory Capital Management Inc. - Defense World
Bank of New York Mellon Corp Has $1.80 Million Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
JPMorgan maintains Overweight rating on iTeos amid TIGIT data By Investing.com - Investing.com Canada
Wedbush Weighs in on iTeos Therapeutics, Inc.’s FY2027 Earnings (NASDAQ:ITOS) - Defense World
FY2027 Earnings Estimate for iTeos Therapeutics, Inc. Issued By Wedbush (NASDAQ:ITOS) - MarketBeat
iTeos Therapeutics (NASDAQ:ITOS) Stock Rating Reaffirmed by HC Wainwright - Defense World
View from ESMO: iTeos data keep TIGIT alive, for now - BioCentury
Iteos Therapeutics Inc (ITOS) 財務データ
収益
当期純利益
現金流量
EPS
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):